leisure time -WSS

leisure time

author：explore 2025-08-31 16:44:23 - browse：53159

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Weight loss drug costs may need more research, senator suggests

WSS

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Synthetic human embryos? Researchers say term is overblown

Brazil's Jair Bolsonaro is barred from running for office until 2030

A daunting task: navigating dual Medicare, Medicaid eligibility

Thousands protest in Iraq for a second day over burning of Quran in Sweden

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Novavax promises a turnaround & Lilly roils the obesity market

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Medical records are filled with copy

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A daunting task: navigating dual Medicare, Medicaid eligibility

How one medical school became remarkably diverse

The simple reason for the increase in autism diagnosis

Medical leaders decry Supreme Court decision on affirmative action

U.K. considers world's first use of meningitis vaccine to address gonorrhea

knowledge

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Why do we get seasonal allergies?

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Supreme Court rules employers must be more accommodating of religious observance

Poor hospice wound care hurts patients and families

hotspot

leisure time

focus

hotspot